← All trials
NCT05034068
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2021
- Primary completion
- Jan 31, 2022
- Completion date
- Feb 28, 2022
- First posted
- Sep 5, 2021
- Last posted
- Sep 5, 2021
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Al Azhar UniversityLead sponsor
- Al Azhar UniversityReponsible party - principal investigator
- Al Azhar UniversityStudy director
- Assiut UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.